BioNTech founder Ugur Sahin confident on making mutation-beating vaccine in six weeks


Ugur Sahin, the co-founder of the German company BioNTech, has said that he was confident about making a mutation-beating vaccine within six weeks. His statement came a day after Sahin said that the COVID-19 vaccine co-developed by his company would also be effective against the new variant of the coronavirus that has sent shockwaves both in the UK and around the world.

According to news agency AFP, Sahin said that ‘scientifically, it is highly likely that the immune response by this vaccine also can deal with the new virus variant.’ The Germann scientist said that, if needed, his company can also ‘directly start to engineer a vaccine which completely mimics this new mutation’ “We could be able to provide a new vaccine technically within six weeks,” Sahin was quoted by AFP as saying.

Earlier, according to Reuters news agency, Sahin had told Bild TV that BioNTech would investigate the mutation in the coming days but that he viewed the matter ‘with a degree of soberness.’

India joined the list of countries on Monday to announce a flight ban to and from the UK in view of the discovery of the new variant of coronavirus, which according to the British health minister, had become ‘out of control. However, the World Health Organisation had cautioned against major alarm, saying that this was a normal part of a pandemic’s evolution.


Please enter your comment!
Please enter your name here